» Articles » PMID: 22710706

Comparison of Relative Versus Absolute Arm Size Change As Criteria for Quantifying Breast Cancer-related Lymphedema: the Flaws in Current Studies and Need for Universal Methodology

Overview
Specialty Oncology
Date 2012 Jun 20
PMID 22710706
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this article is to evaluate arm measurements of breast cancer patients to critically assess absolute change in arm size compared to relative arm volume change as criteria for quantifying breast cancer-related lymphedema (BCRL). We used pre-operative measurements of 677 patients screened for BCRL before and following treatment of unilateral breast cancer at Massachusetts General Hospital between 2005 and 2008 to model the effect of an absolute change in arm size of 200 mL or 2 cm compared to relative arm volume change. We also used sequential measurements to analyze temporal variation in unaffected arm volume. Pre-operative arm volumes ranged from 1,270 to 6,873 mL and correlated strongly (Kendall's τ = 0.55) with body mass index (BMI). An absolute arm volume change of 200 mL corresponded to relative arm volume changes ranging from 2.9 to 15.7 %. In a subset of 45 patients, modeling of a 2-cm change in arm circumference predicted relative arm volume changes ranging from 6.0 to 9.8 %. Sequential measurements of 124 patients with >6 measurements demonstrated remarkable temporal variation in unaffected arm volume (median within-patient change 10.5 %). The magnitude of such fluctuations correlated (τ = 0.36, P < 0.0001) with pre-operative arm volume, patient weight, and BMI when quantified as absolute volume change, but was independent of these variables when quantified as relative arm volume change (P > .05). Absolute changes in arm size used as criteria for BCRL are correlated with pre-operative and temporal changes in body size. Therefore, utilization of absolute volume or circumference change in clinical trials is flawed because specificity depends strongly on patient body size. Relative arm volume change is independent of body size and should thus be used as the standard criterion for diagnosis of BCRL.

Citing Articles

The LYMPH trial: comparing microsurgical with conservative treatment for chronic breast cancer-associated lymphoedema - study protocol of a pragmatic randomised international multicentre superiority trial.

Kappos E, Haas Y, Schulz A, Peters F, Savanthrapadian S, Stoffel J BMJ Open. 2025; 15(2):e090662.

PMID: 39961719 PMC: 11836839. DOI: 10.1136/bmjopen-2024-090662.


Immediate Lymphatic Reconstruction May Decrease the Incidence of Lymphedema in Patients Undergoing Axillary Lymph Node Dissection.

Yakaback S, Fraulin G, Jonsson E, Elmi Assadzadeh G, Bains I, Temple-Oberle C Plast Reconstr Surg Glob Open. 2025; 13(2):e6543.

PMID: 39949575 PMC: 11822335. DOI: 10.1097/GOX.0000000000006543.


Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time.

Kappos E, Fabi A, Halbeisen F, Abu-Ghazaleh A, Stoffel J, Aufmesser-Freyhardt B Breast Cancer Res Treat. 2024; .

PMID: 39653884 DOI: 10.1007/s10549-024-07567-5.


Is axillary web syndrome a risk factor for breast cancer-related lymphedema of the upper extremity? A systematic review and meta-analysis.

Brunelle C, Serig A Breast Cancer Res Treat. 2024; 208(3):471-490.

PMID: 39414730 DOI: 10.1007/s10549-024-07518-0.


Reliability of L-Dex Scores for Assessment of Unilateral Breast Cancer-Related Lymphedema.

Ward L, Gaitatzis K, Thompson B, Paramanandam V, Koelmeyer L Eur J Breast Health. 2024; 20(4):251-257.

PMID: 39323290 PMC: 11589188. DOI: 10.4274/ejbh.galenos.2024.2024-5-7.


References
1.
Ward L, Czerniec S, Kilbreath S . Operational equivalence of bioimpedance indices and perometry for the assessment of unilateral arm lymphedema. Lymphat Res Biol. 2009; 7(2):81-5. DOI: 10.1089/lrb.2008.1027. View

2.
van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R . Lymphedema development following breast cancer surgery with full axillary resection. Lymphology. 2005; 37(4):206-8. View

3.
Armer J, Stewart B, Shook R . 30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA. J Lymphoedema. 2010; 4(1):14-18. PMC: 2826842. View

4.
McLaughlin S, Wright M, Morris K, Giron G, Sampson M, Brockway J . Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008; 26(32):5213-9. PMC: 2652091. DOI: 10.1200/JCO.2008.16.3725. View

5.
Yang E, Park W, Seo K, Kim S, Heo C, Lim J . Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol. 2009; 101(1):84-91. DOI: 10.1002/jso.21435. View